Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2003
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176457 Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003US20030176447 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176429 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
09/18/2003US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176415 1,2,3,4-tetrahydroisoquinoline derivatives
09/18/2003US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors
09/18/2003US20030176390 Methods of treating insulin resistance syndrome and diabetes
09/18/2003US20030176388 Fatty acid synthase mRNA binding protein
09/18/2003US20030176365 To improve cerebral function
09/18/2003US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man
09/18/2003US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes
09/18/2003US20030176346 Using substances that activate the CNTF (ciliary neurotrophic factor) receptor for the preparation of pharmaceutical formulations for therapy of obesity and diseases associated therewith, for example diabetes
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030175963 Platform for the differentiation of cells
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175808 Novel protein and dna thereof
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175366 Plant Extracts and Methods of Treating Skin Therewith
09/18/2003US20030175338 Formulations of atorvastatin stabilized with alkali metal additions
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175313 Preparation of sterile stabilized nanodispersions
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2480001A1 Chain oligolactic acid thioester
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2479036A1 Aryl substituted pyrimidines and the use thereof
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478765A1 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478599A1 Salts of nateglinide
09/18/2003CA2478342A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2478026A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
09/18/2003CA2477984A1 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003CA2477973A1 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003CA2476183A1 Treatment of type i diabetes mellitus using growth hormone antagonist
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/18/2003CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344818A1 Method for culturing Langerhans islets cells
09/17/2003EP1344780A1 Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
09/17/2003EP1344779A1 Azolo-pyrimidines
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1344458A1 Probiotic delivery system
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases
09/17/2003EP1343860A1 A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter
09/17/2003EP1343817A2 Novel treatment
09/17/2003EP1343791A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343773A1 Thiazole derivatives for traeing ppar related disorders
09/17/2003EP1343772A1 Thia- and oxazoles and their use as ppars activators
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP1343763A1 Pyrodone derivatives as ap2 inhibitors
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343517A2 Survical promoting ncam binding and ncam ligand biding compounds
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1343493A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/17/2003EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
09/17/2003EP1343490A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof
09/17/2003EP1343488A1 Treatment of statin side effects
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343479A2 Aerogel powder therapeutic agents
09/17/2003EP1343390A2 Materials and methods for the treatment or prevention of obesity
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1282622B1 Crf receptor antagonists and methods relating thereto
09/17/2003EP1244452B1 Carboxamide derivates of pyrrolidine and piperidine as urotensin-ii receptor antagonists
09/17/2003EP1230230B1 Indeno-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP1091734B1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 1298